MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, BMRN made $3,221,253K in revenue. $348,901K in net income. Net profit margin of 10.83%.

Income Overview

Revenue
$3,221,253K
Net Income
$348,901K
Net Profit Margin
10.83%
EPS
$1.8
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • Europe
    • Rest Of World
    • Others
Revenue Breakdown
    • VOXZOGO
    • VIMIZIM
    • NAGLAZYME
    • Others

Income Statement
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Total revenues
3,221,253 2,853,915 2,419,226 2,096,039
Cost of sales
717,442 580,235 514,854 483,669
Research and development
921,930 747,184 746,773 649,606
Selling, general and administrative
1,153,017 1,009,025 937,291 854,009
Intangible asset amortization
19,386 43,257 --
Intangible asset amortization and contingent consideration
--62,211 67,193
Gain on sale of nonfinancial assets
0 10,000 0 108,000
Total operating expenses
2,811,775 2,369,701 2,261,129 1,946,477
Income from operations
409,478 484,214 158,097 149,562
Interest income
74,904 74,883 58,339 18,034
Interest expense
10,899 12,666 17,335 15,970
Other income (expense), net
8,997 -4,668 -10,538 -2,050
Income before income taxes
482,480 541,763 188,563 149,576
Provision for income taxes
133,579 114,904 20,918 8,015
Net income
348,901 426,859 167,645 141,561
Basic EPS
1.82 2.25 0.89 0.76
Diluted EPS
1.8 2.21 0.87 0.75
Basic Average Shares
191,787,000 190,027,000 187,834,000 185,266,000
Diluted Average Shares
197,394,000 196,708,000 191,595,000 188,963,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
US$1,104,973K Europe$874,331K Rest Of World$544,469K Latin America$435,478K Products ExcludingALDURAZYME-Sales Channel...$2,959,251K ALDURAZYME-Sales Channel ThroughIntermediary$208,508K Product$3,167,759K (12.75%↑ Y/Y)Royalty And Other$53,494K (20.29%↑ Y/Y)Total revenues$3,221,253K (12.87%↑ Y/Y)Income from operations$409,478K (-15.43%↓ Y/Y)Interest income$74,904K (0.03%↑ Y/Y)Total operatingexpenses$2,811,775K (18.66%↑ Y/Y)Other income(expense), net$8,997K (292.74%↑ Y/Y)Income before incometaxes$482,480K (-10.94%↓ Y/Y)Interest expense$10,899K (-13.95%↓ Y/Y)Selling, general andadministrative$1,153,017K (14.27%↑ Y/Y)Research and development$921,930K (23.39%↑ Y/Y)Cost of sales$717,442K (23.65%↑ Y/Y)Intangible assetamortization$19,386K (-55.18%↓ Y/Y)Net income$348,901K (-18.26%↓ Y/Y)Provision for income taxes$133,579K (16.25%↑ Y/Y)

biomarin-logo-svg

BIOMARIN PHARMACEUTICAL INC (BMRN)

biomarin-logo-svg

BIOMARIN PHARMACEUTICAL INC (BMRN)